Subtype
Genitourinary System Carcinoma
CI-CAN-00000925Explore in graph →
1,498 active trials44 approved drugs143 evidence items
- NCIt
- C164141
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00000925Explore in graph →
Clinical trials
4,916 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (758)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01577784 | Pazopanib in Second-line Therapy in Renal Cell Carcinoma | unknown | Phase 2 | 27 | Associació per a la Recerca Oncologica, SpainOTHER | 1 | Mar 12, 2014 | clinicaltrials |
| NCT00684970 | Phase IIB Clinical Trial of Hamsa-1™ in Metastatic Castration Resistant Prostate Cancer (CRPC)(TLH-202) | unknown | Phase 2 | 100 | Tiltan Pharma Ltd.INDUSTRY | 1 | Dec 5, 2013 | clinicaltrials |
| NCT01938339 | Development of Clinical Assessment Technique Using Multi-radiotracer PET/MR in Prostate Cancer | unknown | N/A | 60 | Seoul National University HospitalOTHER | 1 | Dec 5, 2013 | clinicaltrials |
| NCT01993966 | EGCG Modulate the Cytotoxic Effects of Chemotherapeutic Agents in Human Urothelial Carcinoma Cells | unknown | — | 25 | National Taiwan University HospitalOTHER | 1 | Nov 25, 2013 | clinicaltrials |
| NCT01968928 | The Role of Pyruvate Kinase M2 in Growth, Invasion and Drug Resistance in Human Urothelial Carcinoma | unknown | — | 25 | National Taiwan University HospitalOTHER | 1 | Oct 28, 2013 | clinicaltrials |
| NCT01892059 | Study of Segmental Renal Artery Clamping During Laparoscopic Partial Nephrectomy | unknown | N/A | 100 | The First Affiliated Hospital with Nanjing Medical UniversityOTHER | 1 | Jul 3, 2013 | clinicaltrials |
| NCT01456065 | Safety of Active Immunotherapy in Subjects With Ovarian Cancer | unknown | Phase 1 | 15 | Life Research Technologies GmbHOTHER | 2 | Mar 1, 2013 | clinicaltrials |
| NCT01481870 | Comparison of Sequential Therapies With Sunitinib and Sorafenib in Advanced Renal Cell Carcinoma(CROSS-J-RCC) | unknown | Phase 3 | 120 | Yamagata UniversityOTHER | 1 | Feb 25, 2013 | clinicaltrials |
| NCT01246817 | Temsirolimus-RCC-imaging | unknown | Phase 2 | 51 | Radboud University Medical CenterOTHER | 1 | Apr 11, 2012 | clinicaltrials |
| NCT00867633 | Aristolochic Acid-DNA Adduct in Urothelial Carcinoma in Taiwan | unknown | — | 100 | National Taiwan University HospitalOTHER | 1 | Feb 22, 2012 | clinicaltrials |
| NCT01487902 | The Role of Androgen Deprivation Treatment (ADT) in Docetaxe-Prednisolone Chemotherapy for Castrate-Resistant Prostatic Cancer | unknown | Phase 2 | 90 | Asan Medical CenterOTHER | 1 | Dec 8, 2011 | clinicaltrials |
| NCT01478412 | An Evaluation of Polymer Based Fiducials for Use in Imaging Patients Receiving Treatment for Prostate Cancer(Clarity) | unknown | — | 20 | John Chang, MDOTHER | 1 | Dec 7, 2011 | clinicaltrials |
| NCT00777504 | Study to the Optimal Duration of Therapy With Oral Angiogenesis Inhibitors | unknown | Phase 4 | 30 | Radboud University Medical CenterOTHER | 1 | Sep 16, 2011 | clinicaltrials |
| NCT01427101 | Results of CRS and Debulking in PMP Patients | unknown | — | — | Uppsala UniversityOTHER | 0 | Sep 1, 2011 | clinicaltrials |
| NCT01069770 | Neoadjuvant Sunitinib Treatment for Metastatic Clear Cell Renal Cell Carcinoma (RCC) | unknown | Phase 2 | 32 | Korean Urological Oncology SocietyOTHER | 1 | Jun 23, 2011 | clinicaltrials |
| NCT01378052 | DNA Methylation and Urothelial Carcinoma | unknown | — | 200 | China Medical University HospitalOTHER | 1 | Jun 22, 2011 | clinicaltrials |
| NCT01219751 | Trial Of Sunitinib In Advanced Non-Clear Cell Type Renal Cell Carcinoma | unknown | Phase 2 | 35 | Asan Medical CenterOTHER | 1 | Jun 17, 2011 | clinicaltrials |
| NCT01360723 | DNA Methylation and Arsenic-associated Urothelial Carcinoma | unknown | — | 600 | China Medical University HospitalOTHER | 1 | May 27, 2011 | clinicaltrials |
| NCT00862303 | DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating Patients With Renal Cell Carcinoma | unknown | Phase 1 / Phase 2 | 100 | Fuzhou General HospitalOTHER | 1 | Mar 8, 2011 | clinicaltrials |
| NCT01273636 | Risk Factors for Concurrent Endometrial Carcinoma in Patients With a Curettage Diagnosis of Endometrial Hyperplasia | unknown | — | 100 | National Taiwan University HospitalOTHER | 1 | Jan 10, 2011 | clinicaltrials |
| NCT01240005 | Cytokine Induced Killer Cells Stimulated by DC Immunotherapy for Renal Cell Carcinoma | unknown | Phase 1 / Phase 2 | 30 | Qingdao UniversityOTHER | 1 | Nov 15, 2010 | clinicaltrials |
| NCT00610389 | Phase II Study With Immunotherapy With Dendritic Cells and Tumor Infiltrating Lymphocytes in Solid Tumors | unknown | Phase 2 | 27 | Clinica Universidad de Navarra, Universidad de NavarraOTHER | 1 | May 10, 2010 | clinicaltrials |
| NCT01041482 | A Multi-Center, Non-Controlled Clinical Study of Sorafenib Adjuvant Therapy in Advanced Renal-Cell Carcinoma(AGuo) | unknown | Phase 2 | 140 | Chinese Academy of Medical SciencesOTHER | 1 | Jan 6, 2010 | clinicaltrials |
| NCT00869011 | Exercise for Patients With Renal Cell Cancer Receiving Sunitinib | unknown | Phase 3 | 70 | Charite University, Berlin, GermanyOTHER | 1 | Dec 23, 2009 | clinicaltrials |
| NCT00740441 | A Phase II Study of AS1411 in Renal Cell Carcinoma | unknown | Phase 2 | 30 | Antisoma ResearchINDUSTRY | 1 | Sep 25, 2009 | clinicaltrials |
| NCT00945984 | Laparoendoscopic Single-site Radical Nephrectomy for Localized Renal Cell Carcinoma(LESS) | unknown | — | 36 | Seoul National University HospitalOTHER | 1 | Jul 28, 2009 | clinicaltrials |
| NCT00890110 | Autologous Vaccination of Stage 4 Renal Cell Carcinoma Combined With Sunitinib(rcc) | unknown | Phase 1 / Phase 2 | 13 | Hadassah Medical OrganizationOTHER | 0 | Apr 29, 2009 | clinicaltrials |
| NCT00854464 | Arsenic Methylation Enzymes, Cigarette Metabolites, DNA Repair Enzymes, Inflammatory Factors and Urothelial Carcinoma | unknown | — | 420 | National Taiwan University HospitalOTHER | 1 | Mar 3, 2009 | clinicaltrials |
| NCT00816075 | Efficacy of Distilled Water Versus Mitomycin C on Preventing Recurrences of Bladder Cancer After Transurethral Resection | unknown | Phase 2 / Phase 3 | 40 | Bozyaka Training and Research HospitalOTHER | 1 | Feb 17, 2009 | clinicaltrials |
| NCT00764166 | A Prospective Randomized Phase III Study Comparing Hormonal Therapy +/-Docetaxel(RisingPSA) | unknown | Phase 3 | 254 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Oct 1, 2008 | clinicaltrials |
| NCT00715286 | Neoadjuvant Chemotherapy in Advanced Epithelial Ovarian Cancer (EOC): A Phase III Randomized Study | unknown | Phase 3 | 180 | All India Institute of Medical SciencesOTHER | 1 | Jul 15, 2008 | clinicaltrials |
| NCT00673192 | Evaluation of ELISA Assay on Human Papilloma Viruses (HPV) Infection Population | unknown | N/A | 100 | National Taiwan University HospitalOTHER | 1 | May 7, 2008 | clinicaltrials |
| NCT00154986 | IGFBP-3 in Ovarian Cancer Invasion | unknown | N/A | 30 | National Taiwan University HospitalOTHER | 1 | Sep 12, 2005 | clinicaltrials |
| NCT00006431 | Active Immunotherapy Of Metastatic Renal Cell Carcinoma Using Autologous Dendritic Cells Transfected With Autologous Total Tumor RNA | unknown | Phase 1 | — | National Center for Research Resources (NCRR)NIH | 1 | Jun 24, 2005 | clinicaltrials |
Data updated 23 days agoSource updated Mar 12, 2014source: clinicaltrials